GT Biopharma, Inc. (GTBP)
6.27
+0.31
(+5.20%)
USD |
NASDAQ |
Oct 09, 16:00
6.79
+0.52
(+8.29%)
After-Hours: 20:00
GT Biopharma Price : 6.27 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 6.20 | 6.22 | 5.80 | 5.96 | 31765.00 |
| Oct 07, 2026 | 6.30 | 6.47 | 6.20 | 6.20 | 19169.00 |
| Oct 06, 2026 | 6.31 | 6.45 | 6.20 | 6.37 | 22405.00 |
| Oct 05, 2026 | 6.13 | 6.68 | 6.12 | 6.16 | 38732.00 |
| Oct 02, 2026 | 6.36 | 6.51 | 6.00 | 6.10 | 62624.00 |
| Oct 01, 2026 | 6.34 | 6.46 | 6.00 | 6.20 | 39000.00 |
| Sep 30, 2026 | 6.85 | 7.017 | 6.47 | 6.47 | 29759.00 |
| Sep 29, 2026 | 7.08 | 7.10 | 6.710 | 6.875 | 34968.00 |
| Sep 28, 2026 | 7.00 | 7.25 | 6.79 | 6.80 | 36975.00 |
| Sep 25, 2026 | 6.79 | 7.24 | 6.59 | 6.89 | 79842.00 |
| Sep 24, 2026 | 7.01 | 7.10 | 6.59 | 6.83 | 28216.00 |
| Sep 23, 2026 | 7.08 | 7.275 | 6.825 | 7.10 | 53725.00 |
| Sep 22, 2026 | 7.12 | 7.20 | 6.350 | 7.18 | 74674.00 |
| Sep 21, 2026 | 7.16 | 7.82 | 6.880 | 7.18 | 57706.00 |
| Sep 18, 2026 | 7.52 | 7.52 | 7.11 | 7.16 | 37474.00 |
| Sep 17, 2026 | 7.80 | 7.80 | 6.330 | 7.49 | 110656.0 |
| Sep 16, 2026 | 9.04 | 9.04 | 7.31 | 7.81 | 107924.0 |
| Sep 15, 2026 | 10.48 | 10.48 | 8.13 | 9.00 | 335286.0 |
| Sep 14, 2026 | 8.69 | 11.98 | 8.65 | 11.63 | 524297.0 |
| Sep 11, 2026 | 6.59 | 8.820 | 6.59 | 8.61 | 544276.0 |
| Sep 10, 2026 | 6.13 | 6.74 | 5.50 | 6.18 | 161355.0 |
| Sep 09, 2026 | 5.47 | 6.24 | 5.12 | 5.98 | 120048.0 |
| Sep 08, 2026 | 5.62 | 5.95 | 4.910 | 5.240 | 88498.00 |
| Sep 04, 2026 | 6.438 | 6.50 | 5.552 | 6.025 | 46893.00 |
| Sep 03, 2026 | 7.025 | 7.14 | 6.31 | 6.31 | 44634.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.52 |
| Anika Therapeutics, Inc. | 19.58 |
| Savara, Inc. | 4.925 |
| Vericel Corp. | 40.09 |
Price Related Metrics
| Price to Book Value | 3.140 |
| Earnings Yield | -1.44K% |
| Market Cap | 11.20M |